During the past 9 years, Nova Pharma Solutions Bhd's highest 3-Year average EPS without NRI Growth Rate was 18.60% per year. The lowest was -41.50% per year. And the median was -16.65% per year.
Nova Pharma Solutions Bhd EPS (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Nova Pharma Solutions Bhd's EPS (Diluted)
For the Engineering & Construction subindustry, Nova Pharma Solutions Bhd's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Pharma Solutions Bhd's PE Ratio Distribution in the Construction Industry
For the Construction industry and Industrials sector, Nova Pharma Solutions Bhd's PE Ratio distribution charts can be found below:
* The bar in red indicates where Nova Pharma Solutions Bhd's PE Ratio falls into.
Nova Pharma Solutions Bhd EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Nova Pharma Solutions Bhd's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was RM0.03
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nova Pharma Solutions Bhd (XKLS:03006) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Nova Pharma Solutions Bhd EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of Nova Pharma Solutions Bhd's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Nova Pharma Solutions Bhd (XKLS:03006) Business Description
Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKLS:03006 has been successfully added to your 